Clinical Trial Update: Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of Tarlatamab with etoposide, carboplatin, and atezolizumab in transformed small cell lung cancer after EGFR TKI th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Tarlatamab

Snippet

Sponsor: Se-Hoon Lee | Conditions: Small Cell Carcinoma of Lung | Phase 2 | Status: RECRUITING